These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27928961)

  • 21. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
    Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
    J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DARPins against a functional IgE epitope.
    Baumann MJ; Eggel A; Amstutz P; Stadler BM; Vogel M
    Immunol Lett; 2010 Oct; 133(2):78-84. PubMed ID: 20673836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage.
    Eggel A; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    J Mol Biol; 2009 Oct; 393(3):598-607. PubMed ID: 19683003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered Protein Scaffolds as Next-Generation Therapeutics.
    Gebauer M; Skerra A
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():391-415. PubMed ID: 31914898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of Fluorogen-Activating Designed Ankyrin Repeat Proteins (FADAs) as Versatile Sensor Tools.
    Schütz M; Batyuk A; Klenk C; Kummer L; de Picciotto S; Gülbakan B; Wu Y; Newby GA; Zosel F; Schöppe J; Sedlák E; Mittl PRE; Zenobi R; Wittrup KD; Plückthun A
    J Mol Biol; 2016 Mar; 428(6):1272-1289. PubMed ID: 26812208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designed Ankyrin Repeat Proteins: A Look at their Evolving Use in Medicine with a Focus on the Treatment of Chorioretinal Vascular Disorders.
    Smithwick E; Stewart MW
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):33-45. PubMed ID: 28464780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
    Walser M; Mayor J; Rothenberger S
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational Modeling of Designed Ankyrin Repeat Protein Complexes with Their Targets.
    Radom F; Paci E; Plückthun A
    J Mol Biol; 2019 Jul; 431(15):2852-2868. PubMed ID: 31082438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational flexibility of an anti-IL-13 DARPin†.
    Teplyakov A; Malia TJ; Obmolova G; Jacobs SA; O'Neil KT; Gilliland GL
    Protein Eng Des Sel; 2017 Jan; 30(1):31-37. PubMed ID: 27881684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DARPins and other repeat protein scaffolds: advances in engineering and applications.
    Boersma YL; Plückthun A
    Curr Opin Biotechnol; 2011 Dec; 22(6):849-57. PubMed ID: 21715155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid selection of high-affinity binders using ribosome display.
    Dreier B; Plückthun A
    Methods Mol Biol; 2012; 805():261-86. PubMed ID: 22094811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hot-spot motif characterizes the interface between a designed ankyrin-repeat protein and its target ligand.
    Cheung LS; Kanwar M; Ostermeier M; Konstantopoulos K
    Biophys J; 2012 Feb; 102(3):407-16. PubMed ID: 22325262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chaperone-assisted structure elucidation with DARPins.
    Mittl PR; Ernst P; Plückthun A
    Curr Opin Struct Biol; 2020 Feb; 60():93-100. PubMed ID: 31918361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species.
    Zadravec P; Štrukelj B; Berlec A
    Appl Environ Microbiol; 2015 Mar; 81(6):2098-106. PubMed ID: 25576617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rigid fusions of designed helical repeat binding proteins efficiently protect a binding surface from crystal contacts.
    Ernst P; Honegger A; van der Valk F; Ewald C; Mittl PRE; Plückthun A
    Sci Rep; 2019 Nov; 9(1):16162. PubMed ID: 31700118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific targeting of human caspases using designed ankyrin repeat proteins.
    Flütsch A; Schroeder T; Barandun J; Ackermann R; Bühlmann M; Grütter MG
    Biol Chem; 2014 Oct; 395(10):1243-52. PubMed ID: 25153593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer Therapy.
    Gabriele F; Palerma M; Ippoliti R; Angelucci F; Pitari G; Ardini M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ankyrin repeat as molecular architecture for protein recognition.
    Mosavi LK; Cammett TJ; Desrosiers DC; Peng ZY
    Protein Sci; 2004 Jun; 13(6):1435-48. PubMed ID: 15152081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of protein stability using ribosome display.
    Buchanan A
    Methods Mol Biol; 2012; 805():191-212. PubMed ID: 22094807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residue-resolved stability of full-consensus ankyrin repeat proteins probed by NMR.
    Wetzel SK; Ewald C; Settanni G; Jurt S; Plückthun A; Zerbe O
    J Mol Biol; 2010 Sep; 402(1):241-58. PubMed ID: 20654623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.